Literature DB >> 31789266

Rosacea associated with increased risk of generalized anxiety disorder: a case-control study of prevalence and risk of anxiety in patients with rosacea.

Pinar Incel Uysal1, Neslihan Akdogan2, Yildiz Hayran2, Ayse Oktem2, Basak Yalcin2.   

Abstract

BACKGROUND: Rosacea may result in emotional distress and anxiety. However, data on the presence of generalized anxiety disorder in rosacea patients are scarce.
OBJECTIVE: The aim of the study was to detect the frequency and level of anxiety and depression in patients with rosacea.
METHODS: A total of 194 consecutive rosacea patients and 194 age- and sex-matched controls were enrolled. Severity of rosacea was assessed in patients according to the criteria of the National Rosacea Society Ethics Committee. Both patients and controls were evaluated by the Generalized Anxiety Disorder 7-item scale, and severity was measured by the Generalized Anxiety Disorder-Adult.
RESULTS: Individuals who were diagnosed with an anxiety and/or depressive disorder were more common in patient group (24.7% vs. 7.2%, p<0,01). Female patients were particularly at risk for having generalized anxiety disorder (OR=2.8; 95% CI 1.15-7.37; p=0.02). STUDY LIMITATIONS: Single center study and limited sample size.
CONCLUSIONS: Rosacea patients show greater risk of having anxiety disorders, including generalized anxiety disorder. Female patients, those with lower educational levels, those with phymatous subtype, untreated patients, and patients with prior psychiatric morbidity may be at particular risk for anxiety. It is essential to consider the psychological characteristics of patients to improve their well-being.
Copyright © 2019. Published by Elsevier España, S.L.U.

Entities:  

Keywords:  Anxiety; Anxiety disorders; Depression; Rosacea

Year:  2019        PMID: 31789266     DOI: 10.1016/j.abd.2019.03.002

Source DB:  PubMed          Journal:  An Bras Dermatol        ISSN: 0365-0596            Impact factor:   1.896


  4 in total

Review 1.  The link between cutaneous inflammation and cognitive impairment.

Authors:  S Wen; P M Elias; J S Wakefield; T M Mauro; M-Q Man
Journal:  J Eur Acad Dermatol Venereol       Date:  2022-07-02       Impact factor: 9.228

Review 2.  Updates on the Risk of Neuropsychiatric and Gastrointestinal Comorbidities in Rosacea and Its Possible Relationship with the Gut-Brain-Skin Axis.

Authors:  Yu Ri Woo; Yu Jin Han; Hei Sung Kim; Sang Hyun Cho; Jeong Deuk Lee
Journal:  Int J Mol Sci       Date:  2020-11-10       Impact factor: 5.923

3.  Depression and Anxiety in Rosacea Patients: A Systematic Review and Meta-Analysis.

Authors:  Ru Dai; BingJiang Lin; Xuetong Zhang; Yuchen Lou; Suling Xu
Journal:  Dermatol Ther (Heidelb)       Date:  2021-10-18

4.  Prevalence and Risk Factors of Anxiety and Depression in Rosacea Patients: A Cross-Sectional Study in China.

Authors:  Mengting Chen; Zhili Deng; Yingxue Huang; Ji Li
Journal:  Front Psychiatry       Date:  2021-06-16       Impact factor: 4.157

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.